Showing 611-620 of 6902 results for "".
Neck and Back Pain: When Should You Refer Your Patients to a Neurosurgeon?
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/when-to-refer-neck-and-back-pain-patients-to-a-neurosurgeon/8478/Dr. Patrick Connolly discusses when to consider referring patients to neurosurgeons for neck and back pain, and the best surgical options available.Test Your Skills and Learn From Experts on Best Practice in Diagnosis and Management of Systemic Mastocytosis
https://reachmd.com/programs/cme/test-your-skills-and-learn-from-experts-on-best-practice-in-diagnosis-and-management-of-systemic-mastocytosis/54694/On-demand webcast featuring expert-informed best practices for diagnosing and managing patients with systemic mastocytosis (SM) as well as the latest data on new and emerging SM therapies.Obesity: What You May Not Know
https://reachmd.com/programs/clinicians-roundtable/obesity-what-you-may-not-know/2729/Dr. Cynthia Bulik from UNC is a noted researcher in the field of Eating Disorders and Obesity. Join Dr. Shira Johnson as she interviews Dr. Bulik and discusses prevalence, the emerging roles of families, and the important functions of the Primary Care Provider."Tom is engaging with all of the patients you aren't seeing today–that's the actual power," says Jean-Claude Saghbini from Lumeris
https://reachmd.com/programs/the-convergence/tom-jean-claude-saghbini-lumeris/39925/Primary care is facing a massive supply-demand gap—and artificial intelligence (AI) may finally offer a scalable solution. In this episode of The Convergence, Dr. Brian McDonough speaks with Jean-Claude Saghbini, Chief Technology Officer at Lumeris, about “Tom,” an agentic AI tool designed to reduceWhen Your Patient Has a Spinal Deformity: Clinical Priorities
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/when-your-patient-has-a-spinal-deformity-clinical-priorities/9991/Orthopaedic Surgery Expert Dr. Comron Saifi reviews assessment and treatment options for spinal deformities.Screening for Prediabetes in Youth with Obesity: Evaluating the TyG Index
https://reachmd.com/programs/clinicians-roundtable/screening-for-prediabetes-in-youth-with-obesity-evaluating-the-tyg-index/39651/A cross-sectional study in Frontiers in Endocrinology assessed the triglyceride–glucose (TyG) index as a potential screening marker for prediabetes in children and adolescents with obesity. Hear from ReachMD's Ryan Quigley as he discusses the findings from this research and explores how the TyGWhat Do the Updated Medicare Payment Policies Mean for You?
https://reachmd.com/programs/perspectives-ama/what-do-the-updated-medicare-payment-policies-mean-for-you/10607/Join AMA President Dr. McAneny as she guides us through changes to the physician fee schedule and organized medicine’s response to these changes.Hold the Sunscreen: Your Body Needs That Vitamin D
https://reachmd.com/programs/clinicians-roundtable/hold-the-sunscreen-your-body-needs-that-vitamin-d/4149/Doctors are soaking up the latest information and making sure their patients are getting the proper levels of Vitamin D.Clinical Conversations: A conversation with Dr Angela Lamb, a dermatologist and professor in New York, New York
https://reachmd.com/programs/nemluvio-peer-network/clinical-conversations-a-conversation-with-dr-angela-lamb-a-dermatologist-and-professor-in-new-york-new-york/37237/Dr Angela Lamb discusses her approach to treating prurigo nodularis (PN) and atopic dermatitis (AD). She’ll explain how NEMLUVIO®, the first and only neuroimmune-targeted therapy that blocks IL-31RA, targets both immune and neuronal pathways and addresses chronic itch, inflammation, and barrier disrOctane Aesthetics Tech Forum: 2026 to Be Year of Bioregenerative Therapy
https://reachmd.com/conferences/octane-atf-2026/octane-aesthetics-tech-forum-2026-to-be-year-of-bioregenerative-therapy/54703/At the 2026 Octane Aesthetics Tech Forum, Kay Durairaj, MD, founder of Beauty by Dr. Kay, sat down with Modern Aesthetics to discuss how bioregenerative therapies, such as peptides and skin maintenance with collagen stimulators, will take 2026 by storm.